110 related articles for article (PubMed ID: 22365473)
1. [Auditory and vestibular findings in Fabry disease: a study of 25 patients].
Pichon M; Lidove O; Roudaire ML; Barry B; Herman P; Gobert D; Pasqualoni E; Compain C; Chauveheid MP; Papo T
Rev Med Interne; 2012 Jul; 33(7):364-9. PubMed ID: 22365473
[TBL] [Abstract][Full Text] [Related]
2. Auditory and vestibular findings in Fabry disease: a study of hemizygous males and heterozygous females.
Conti G; Sergi B
Acta Paediatr Suppl; 2003 Dec; 92(443):33-7; discussion 27. PubMed ID: 14989464
[TBL] [Abstract][Full Text] [Related]
3. Inner ear involvement in Anderson-Fabry disease: long-term follow-up during enzyme replacement therapy.
Sergi B; Conti G; Paludetti G;
Acta Otorhinolaryngol Ital; 2010 Apr; 30(2):87-93. PubMed ID: 20559478
[TBL] [Abstract][Full Text] [Related]
4. Inner ear involvement in Fabry disease: Clinical and audiometric evaluation of a large cohort of patients followed in a reference centre.
Rodrigues J; Azevedo O; Sousa N; Cunha D; Mexedo A; Fonseca R
Eur J Med Genet; 2018 Jun; 61(6):341-347. PubMed ID: 29307789
[TBL] [Abstract][Full Text] [Related]
5. Hearing loss in adult patients with Fabry disease treated with enzyme replacement therapy.
Suntjens EB; Smid BE; Biegstraaten M; Dreschler WA; Hollak CE; Linthorst GE
J Inherit Metab Dis; 2015 Mar; 38(2):351-8. PubMed ID: 25395255
[TBL] [Abstract][Full Text] [Related]
6. The hearing status in 12 female and 15 male Japanese Fabry patients.
Sakurai Y; Kojima H; Shiwa M; Ohashi T; Eto Y; Moriyama H
Auris Nasus Larynx; 2009 Dec; 36(6):627-32. PubMed ID: 19261412
[TBL] [Abstract][Full Text] [Related]
7. [Vestibular and cochlear manifestations in Fabry's disease].
Malinvaud D; Germain DP; Benistan K; Bonfils P
Rev Med Interne; 2010 Dec; 31 Suppl 2():S251-6. PubMed ID: 21211674
[TBL] [Abstract][Full Text] [Related]
8. End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry.
Ortiz A; Cianciaruso B; Cizmarik M; Germain DP; Mignani R; Oliveira JP; Villalobos J; Vujkovac B; Waldek S; Wanner C; Warnock DG
Nephrol Dial Transplant; 2010 Mar; 25(3):769-75. PubMed ID: 19846394
[TBL] [Abstract][Full Text] [Related]
9. Characterization of vertigo and hearing loss in patients with Fabry disease.
Köping M; Shehata-Dieler W; Schneider D; Cebulla M; Oder D; Müntze J; Nordbeck P; Wanner C; Hagen R; Schraven SP
Orphanet J Rare Dis; 2018 Aug; 13(1):137. PubMed ID: 30111353
[TBL] [Abstract][Full Text] [Related]
10. Cochleovestibular involvement in patients with Fabry disease: data from the multicenter cohort FFABRY.
Asquier-Khati A; Mauhin W; Michel G; Gendre A; Durant C; Lavigne C; Maillard H; Lacombe D; Willems M; Lidove O; Masseau A
Eur Arch Otorhinolaryngol; 2022 Mar; 279(3):1639-1644. PubMed ID: 34825971
[TBL] [Abstract][Full Text] [Related]
11. Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy.
Ortiz A; Oliveira JP; Waldek S; Warnock DG; Cianciaruso B; Wanner C;
Nephrol Dial Transplant; 2008 May; 23(5):1600-7. PubMed ID: 18175781
[TBL] [Abstract][Full Text] [Related]
12. Hearing loss in Fabry disease: the effect of agalsidase alfa replacement therapy.
Hajioff D; Enever Y; Quiney R; Zuckerman J; Mackermot K; Mehta A
J Inherit Metab Dis; 2003; 26(8):787-94. PubMed ID: 14739683
[TBL] [Abstract][Full Text] [Related]
13. Cardiac and renal dysfunction is associated with progressive hearing loss in patients with Fabry disease.
Köping M; Shehata-Dieler W; Cebulla M; Rak K; Oder D; Müntze J; Nordbeck P; Wanner C; Hagen R; Schraven S
PLoS One; 2017; 12(11):e0188103. PubMed ID: 29161295
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular outcomes in Fabry disease are linked to severity of chronic kidney disease.
Talbot AS; Lewis NT; Nicholls KM
Heart; 2015 Feb; 101(4):287-93. PubMed ID: 25381325
[TBL] [Abstract][Full Text] [Related]
15. Cochleovestibular manifestations in Fabry disease: Importance of screening and systematic ENT evaluation.
Eyermann C; Raguin T; Rohmer D; Noel E; Charpiot A
Eur Ann Otorhinolaryngol Head Neck Dis; 2019 Sep; 136(4):273-279. PubMed ID: 31072727
[TBL] [Abstract][Full Text] [Related]
16. Progressive hearing loss in Fabry's disease: a case report.
Barras FM; Maire R
Eur Arch Otorhinolaryngol; 2006 Jul; 263(7):688-91. PubMed ID: 16521018
[TBL] [Abstract][Full Text] [Related]
17. Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease.
Ries M; Kim HJ; Zalewski CK; Mastroianni MA; Moore DF; Brady RO; Dambrosia JM; Schiffmann R; Brewer CC
Brain; 2007 Jan; 130(Pt 1):143-50. PubMed ID: 17105746
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of vestibular function in patients with chronic suppurative otitis media.
Mostafa BE; Shafik AG; El Makhzangy AM; Taha H; Abdel Mageed HM
ORL J Otorhinolaryngol Relat Spec; 2013; 75(6):357-60. PubMed ID: 24480873
[TBL] [Abstract][Full Text] [Related]
19. [The cochlea in Fabry disease: a sensorineural hearing loss model of vascular origin?].
Malinvaud D; Avan P; Germain DP; Benistan K; Bonfils P
Rev Med Interne; 2006 Jul; 27(7):527-31. PubMed ID: 16413636
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of patients with Fabry disease in Argentina].
AADELFA (Asociación Argentina de estudio de enfermedad de Fabry y otras enfermedades lisosomales)
Medicina (B Aires); 2010; 70(1):37-43. PubMed ID: 20228022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
